Experimental cancer drug helps man who 'should have died'

Sunday, 17 May 2015

Charlotte ObserverExperimental cancer drug helps man who 'should have died'Charlotte ObserverChristopher Lawing has lived three years longer than predicted when he was diagnosed with advanced kidney cancer. He still gets infusions of an immunotherapy drug every 21 days at Levine Cancer Institute. Nurse Cori Fappiano says, “He's one of our ...